Suppressed apoptotic susceptibility in human endometrial epithelial cells pretreated with hepatocyte growth factor

Clinical and Experimental Obstetrics and Gynecology

Volumn 25, Issue 4, 1998, Pages 125-128

  Tanaka, T ^a   Mizuno, K ^a   Umesaki, N ^a   Ogita, S ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; C met; Endometrium; HGF; Menstruation

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; SCATTER FACTOR;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; ENDOMETRIUM; HUMAN; HUMAN CELL;

ADENOCARCINOMA; ANTIGENS, CD95; APOPTOSIS; CELL DIVISION; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; EPITHELIUM; FEMALE; FLOW CYTOMETRY; HEPATOCYTE GROWTH FACTOR; HUMANS; MENSTRUATION; PROTO-ONCOGENE PROTEINS C-MET; TUMOR CELLS, CULTURED;

EID: 0032416065     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kokawa K., Shikone T., Nakano R.: "Apoptosis in the human uterine endometrium during the menstrual cycle". J. Clin. Endocrinol. Metab., 1996, 81, 4144.
2. Tabibzadeh S.: "Signals and molecular pathways involved in apoptosis, with special emphasis on human endometrium". Hum. Reprod. Update. 1995, 1, 303.
3. Watanabe H., Kanzaki H., Narukawa S., Inoue T., Katsuragawa H., Kaneko Y., Mori T.: "Bc1-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis". Am. J. Obstet. Gynecol., 1997, 176, 360.
4. Tabibzadeh S., Babaknia A., Liu R., Zupi E., Marconi D., Romanini C.: "Site and menstrual cycle-dependent expression of proteins of the TNF receptor family, and BCL-2 oncoprotein and phase specific production of TNF- in human endometrium". Human Reprod., 1994, 10, 277.
5. Yamashita H., Kumagai K , Inoki C., Ueki M., Sugimoto O., Otsuki Y.: "The expression of Fas antigen in human endometrium". Acta Obstet. Gynecol. Jpn., 1995, 47, 277.
6. Gompel A., Sabourin J. C., Martin A., Yaneva H., Audouin J., Decroix Y., Poitout P.: "Bcl-2 expression in normal endometrium during the menstrual cycle". Am. J. Pathol., 1994, 144, 1195.
7. Otsuki Y., Misaki O., Sugimoto O., Ito Y., Tsujimoto Y., Akao Y: "Cyclic bc1-2 gene expression in human uterine endometrium during menstrual cycle". Lancet., 1994, 344, 28.
8. Negami A. I., Sasaki H., Kawakami Y., Kamitani N., Kotsuji F., Tominaga T., Nakamura T.: "Serum human hepatocyte growth factor in human menstrual cycle and pregnancy: a novel serum marker of regeneration and reconstruction of human endometrium". Horm. Res., 1995, 44 Suppl. 2, 42.
9. Tominaga T.: "Studies on the mechanism of embryo implantation". Acta Obstet. Gynecol Jpn., 1996, 48.
10. Revoltella R. P., Borney F., Dal-Canto B., D'Urso C. M.: "Apoptosis of serum-free C2.8 mouse embryo hepatocytic cells caused by hepatocyte growth factor deprivation". Cytotechnology, 1993, 13, 13.
11. Revoltella R. P., Dal Canto B., Caracciolo L , D'Urso C. M : "L-carnitine and some of its analogs delay the onset of apoptotic cell death initiated in murine C2 8 hepatocytic cells after hepatocyte growth factor deprivation". Biochem. Biophys. Acta., 1994, 1224, 333.
12. Morita M., Watanahe Y., Akaike T.: "Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hapatocytes" Hepatology, 1995, 21, 1585.
13. Nagy P., Bisgaard H. C., Santoni-Rugiu E., Thorgeirsson S. S.: "In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluorene". Hepatology, 1996, 23, 71.
14. Shen K., Noval R. F.: "Fas-signaling and effects on receptor tyrosine kinase signal transduction in human breast epithelial cells". Biochem. Biophys. Res. Commun., 1997, 230, 89.
15. Ishiwata I., Ishiwata C., Soma M., Arai J., Ishikawa H.: "Establishment of human endometrial adenocarcinoma cell line containing estradiol-17ß and progesterone receptors". Gynecol. Oncol., 1984, 17, 281.
16. Tanaka T., Umesaki N., Mizuno K., Chang L., Miyama M., Ohtaki S., Ogita S.: "Enhancement of apoptotic susceptibility in human endometrial epithelial cell line HHUA by transforming growth factor-ß1". Horm. Metab. Res., 1998, 30, 61.
17. Nagata S.: "Apoptosis by death receptor". Cell., 1997, 88, 355.
18. Park M., Dean M., Cooper C. S., Schmidt M., O'Brien S. J., Blair D. G., Woude G F. V., "Mechanism of met oncogene activation". Cell., 1986, 45, 895.
19. Eischen C. M., Dick C. J., Leibson P. J.: "Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis". J. Immunol., 1994, 153, 1947.
20. Szabo I., Gulbins E., Apfel H., Zhang X., Barth P., Busch A. E. et al.: "Tyrosine phosphorylation-dependent suppression of a voltage-gated K + channel in T lymphocytes upon Fas stimulation". J. Biol. Chem., 1996, 271, 20465.
21. Schlottmann K. E., Gulbins E., Lau S. M., Coggeshall K. M.: "Activation of Src-family tyrosine kinases during Fas-induced apoptosis". J. Leuko. Biol., 1996, 60, 546.
22. Abreu-Martin M. T., Vidrich A., Lynch D. H., Targan S. R.: "Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen". J. Immunol., 1995, 155, 4147.
23. Mollereau B., Deckert M., Deas O., Rieux-Laucat F., Hirsch F., Bernard A. et al.: "CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation". J. Immunol., 1996, 156, 3184.
24. Janssen O., Lengl-Janssen B., Oberg H. H., Robertson M. J., Kabelitz D.: "Induction of cell death via Fas (CD95, Apo-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation" Immunol. Lett., 1996, 49, 63.
25. Atkinson E. A., Ostergaard H., Kane K., Pinkoski M. J., Caputo A., Olszowy M. W., Bleackley R. C., "A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT". J. Biol. Chem., 1996, 271, 5968.
26. Schraven B., Peter M. E.: "APO-1(CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45". FEBS Lett., 1995, 368, 491.
27. Latinis K. M., Koretzky G. A.: "Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells". Blood, 1996, 87, 871.